DAFTAR PUSTAKA

1. Camargo, LA, Pereira CA. 2010. Dyspnea in COPD: Beyond the modified
medical research council scale. J Bras Pneumol.2010; 36 (5): 571-8
2. Susanti, PFE. 2015. Pengaruh Merokok Terhadap Penyakit Paru Obstruktif
Kronik. Fakultas Kedokteran Universitas Lampung. J Majority: vol 4 no 5.
3. Calverley PM, Anderson JA, et al. 2007. Salmeterol and fl uticasone
propionate and survival in chronic obstructive pulmonary disease. N Engl J
Med, 356:775–89.
4. Spencer S, Jones PW. 2003. Time course of recovery of health status following
an infective exacerbation of chronic bronchitis. Thorax, 58:589–93.
5. PDPI. 2011. Penyakit Paru Obstruktif Kronik (PPOK): Pedoman Diagnosis dan
Penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia. Jakarta.
6. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017. Global
Strategy for The Diagnosis, Management, and Prevention of Chronic
Obstructive Pulmonary Disease. Update 2017.
7. Senior RM, Atkinson JJ. 2008. Chronic Obstructive Pulmonary Disease:
Epidemiology, Pathofisiology, and Pathogenesis. Fishman’s Pulmonary
Disease and Disorders. 4th eds. Newyork: The McGraw Hill Companies: 707-
28
8. White, A.J. Gompertz., Stockley.2003. Chronic Obstrctive Pulmonary Disease.
6 : The Aetiology of Exacerbation. Thoracksjournal : vol.58:73-80.
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD).2009. Global
Strategy for The Diagnosis, Management, and Prevention of Chronic
Obstructive Pulmonary Disease. 2009.
10. Tam A, Churg A, Wright JL, et al. 2016. Sex Differences in Airway Remodeling in
a Mouse Model of Chronic Obstructive Pulmonary Disease. Am J Respir Crit
Care Med 2016; 193(8): 825-34.
11. Silva GE, Sherrill DL, Guerra S, Barbee RA. 2004. Asthma as a risk factor for
COPD in a longitudinal study. Chest 2004; 126(1): 59-65.
12. Aida M. Yousef, Wael Alkhiary. 2017. Role of neutrophil to lymphocyte ratio
in prediction of acute exacerbation of chronic obstructive pulmonary disease.
Egyptian Journal of Chest Diseases and Tuberculosis (2017) 66, 43–48.
13. Muhammad, dkk. 2012. Peran Skor COPD Aseessment Test (CAT) sebagai
Prediktor Kejadian Eksaserbasi Akut Penyakit Paru Obstruktif Kronik pada
Jemaah Haji Provinsi DKI Jakarta Tahun 2012. Ina J Chest Crit and Emerg
Med | Vol. 1, No. 2 | June - August 2014.

55
14. Anthonisen NR, Manfreda J, et al. 1987. Antibiotic therapy in exacerbations of
chronic obstructive pulmonary disease. Ann Intern Med, 106:196–204.
15. Attiya Siddiqi, Sanjay Sethi. 2008. Optimizing antibiotic selection in treating
COPD Exacerbations. International Journal of COPD 2008:3(1)
16. Uzun S, Djamin RS, Kluytmans JA, et al. 2014. Azithromycin maintenance
treatment in patients with frequent exacerbations of chronic obstructive
pulmonary disease (COLUMBUS): a randomised, double- blind, placebo-
controlled trial. The Lancet Respiratory medicine 2014; 2(5): 361-8.
17. Decramer M, Rutten-van Mo¨ lken M, Dekhuijzen PR, Troosters T, van
Herwaarden C, Pellegrino R, van Schayck CO, Olivieri D, Del Donno M, De
Backer W, et al. 2005. Effects of N-acetylcysteine on outcomes in chronic
obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility
Study, BRONCUS): a randomised placebo-controlled trial. Lancet
2005;365:1518–1520.
18. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes
NC. 2006.. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev 2006; (2): CD004403.
19. Centers for Disease Control and Prevention (CDC). 2003. Guidelines for
preventing health-care-associated pneumonia, 2003. MMWR Recomm Rep
2004;53:1–36.
20. Andreanne, G., Genevieve, C., Claude, P. 2011. Prevalence of Dyspepsia in
COPD Patients : Experience in a Large Canadian Cohort, European
Respiratory Journal, Volume 38 : 3480.
21. Mandell, et al. 2007. Infectious Diseases Society of America/American
Thoracic Society Consensus Guidelines on the Management of Community-
Acquired Pneumonia in Adults. IDSA/ATS Guidelines for CAP in Adults • CID
2007:44.
22. Am J Respir Crit Care Med. 2005. Guidelines for the Management of Adults
with Hospital-acquired, Ventilator-associated, and Healthcare-associated
Pneumonia. American Journal Of Respiratory And Critical Care Medicine Vol
171 2005. pp 388–416.

56